On February 5, 2024 Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, reported that CEO Dr. Adi Mor and other members of its senior management team will participate in two upcoming investor conferences. Dr. Mor will deliver a corporate presentation and participate in one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference, February 13-14, 2024 (virtual), and the Leerink Partners Global Biopharma Conference, March 11-13, 2024 in Miami, Florida (Press release, Chemomab, FEB 5, 2024, View Source [SID1234639839]). The Oppenheimer Conference presentation will be webcast live and will be available on the investor relations section of the Chemomab website for 90 days.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Oppenheimer 34th Annual Healthcare Life Sciences Conference
Date:
February 14, 2024
Time:
8:00 am ET
Venue:
Virtual
Format:
Webcast presentation
Webcast Link:
Information:
Leerink Partners Global BioPharma Conference
Date:
March 12, 2024
Time:
10:40am ET
Venue:
Fontainebleau Hotel
Format:
Live presentation
Information: